Author

Cathal Harmon

Moderna Therapeutics (United States)ORCID 0000-0001-6728-910XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Cathal Harmon1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Alec W. FreyniD· 2 shared Andrea Carfı́iD· 2 shared Daniel L. MakrinosiD· 2 shared Kath Hardcastle· 2 shared Ziqiu WangiD· 2 shared Adrian R. LaciakiD· 1 shared Amy Gorrie· 1 shared Anthony T. DiPiazzaiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alec W. FreynORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 17, 2025

Convergent Signals Encode Persistent Memory of Resilient States

Teresa Femenía, Hannah Prendeville, Na Sun…·Leandro Z. Agudelo

The paper identifies convergent signals that encode epigenetic memory of adaptive states in NK cells under dietary restriction, showing how these signals reduce DNA damage and enhance metabolic plasticity.

1 citation

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 5, 2025

A multivalent mRNA-LNP therapeutic vaccine with broad cross-genotype immunogenicity elicits clearance of HBV infected hepatocytes

Daniel L. Makrinos, Yanbo Sun, Heather L. Davis…·Simone Pecetta

This paper develops an mRNA-LNP vaccine, mRNA-1965, that clears HBV-infected hepatocytes in mice by inducing broad immune responses across HBV genotypes.

DOI 10.64898/2025.12.03.692117

mousenon-human primate

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 16, 2025

mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize contemporary JN.1-lineage viruses

Arshan Nasir, Diana Wing Lee, Ziqiu Wang…·Alec W. Freyn

This study develops and evaluates two mRNA vaccines targeting the LP.8.1 variant of SARS-CoV-2, showing broad neutralization against JN.1-lineage subvariants.

1 citation

mouseexperimental assay

𝕏 PostBluesky